AARD Share Price Performance
US$5.70
-8.22 (-59.05%)
Price US$5.70
Share Pricen/a
No recently updated narratives available.
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.